SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020521
Filing Date
2018-08-08
Accepted
2018-08-08 16:30:56
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20180630.htm 10-Q 1896510
2 EX-31.1 myok-ex311_9.htm EX-31.1 15762
3 EX-31.2 myok-ex312_8.htm EX-31.2 15846
4 EX-32.1 myok-ex321_7.htm EX-32.1 8818
  Complete submission text file 0001564590-18-020521.txt   7171211

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT myok-20180630.xml EX-101.INS 1795822
6 XBRL TAXONOMY EXTENSION SCHEMA myok-20180630.xsd EX-101.SCH 47530
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20180630_cal.xml EX-101.CAL 38745
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20180630_def.xml EX-101.DEF 144376
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20180630_lab.xml EX-101.LAB 310418
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20180630_pre.xml EX-101.PRE 264157
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 181001815
SIC: 2834 Pharmaceutical Preparations